14-day Premium Trial Subscription Sign Up For FreeGet Free

Eyegate Pharmaceuticals Stock Forecast NASDAQ:EYEG

$1.95 (0%)

Volume: 0

Closed: Dec 03, 2021

Hollow Logo Score: 0.000

Eyegate Pharmaceuticals Stock Forecast

$1.95 (0%)

Volume: 0

Closed: Dec 03, 2021

Score Hollow Logo 0.000

Eyegate Pharmaceuticals Stock Forecast NASDAQ:EYEG

Price Target and Analyst Ratings

Most Recent Rating

On Sep 09, 2021 "HC Wainwright" gave "$11.00" rating for EYEG. The price target was changed from $1.58 to 0.6%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-09-09 $11.00 Reiterated by HC Wainwright $1.61 $1.58→0.6%
2021-08-17 $10.75 - $9.50 Target Lowered by Alliance Global Partners $1.64 $1.60+1.3%
2021-08-17 $10.75 - $9.50 Reiterated by Alliance Global Partners $1.64 $1.73+9.5%
2021-08-16 $14.00 - $11.00 Target Lowered by HC Wainwright $1.58 $1.54→5.5%
2021-05-18 Buy Target Raised by Alliance Global Partners $4.19 $10.25 → $10.75
2021-05-18 Buy Reiterated by Alliance Global Partners $4.19 $10.25 → $10.75
2021-03-31 Buy Target Lowered by Alliance Global Partners $4.98 $16.75 → $10.25
2021-03-31 Buy Reiterated by Alliance Global Partners $4.98 $16.75 → $10.25
2021-02-04 Target Raised by Alliance Global Partners $7.30 $15.50 → $16.75
2020-12-22 Buy Target Raised by HC Wainwright $5.71 $10.00 → $14.00
2020-12-22 Buy Target Raised by Alliance Global Partners $5.71 $9.50 → $15.50
2020-12-22 Buy Reiterated by HC Wainwright $5.71 $10.00 → $14.00
2020-11-12 Buy Target Lowered by HC Wainwright $3.29 $12.00 → $10.00
2020-07-21 Buy Initiated by Alliance Global Partners $4.90 $9.50
2020-06-12 Buy Reiterated by HC Wainwright $5.24
2020-05-19 Buy Reiterated by HC Wainwright $5.16 $12.00

EYEG Stock Trend

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 7.92% during the next 3 months and, with a 90% probability hold a price between $1.90 and $2.56 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-12-07 $1.76 $2.07 $2.38
2021-12-08 $1.77 $2.07 $2.38
2021-12-09 $1.77 $2.08 $2.38
2021-12-10 $1.77 $2.08 $2.39
2021-12-13 $1.78 $2.08 $2.39
2021-12-14 $1.78 $2.09 $2.39
2021-12-15 $1.78 $2.09 $2.40
2021-12-16 $1.78 $2.09 $2.40
2021-12-17 $1.79 $2.09 $2.40
2021-12-20 $1.79 $2.10 $2.40
2021-12-21 $1.79 $2.10 $2.41
2021-12-22 $1.80 $2.10 $2.41
2021-12-23 $1.80 $2.11 $2.41
2021-12-27 $1.80 $2.11 $2.42
2021-12-28 $1.80 $2.11 $2.42
2021-12-29 $1.81 $2.11 $2.42
2021-12-30 $1.81 $2.12 $2.42
2021-12-31 $1.81 $2.12 $2.43
2022-01-03 $1.81 $2.12 $2.43
2022-01-04 $1.82 $2.13 $2.43
2022-01-05 $1.82 $2.13 $2.44
2022-01-06 $1.82 $2.13 $2.44
2022-01-07 $1.83 $2.13 $2.44
2022-01-10 $1.83 $2.14 $2.44
2022-01-11 $1.83 $2.14 $2.45
2022-01-12 $1.83 $2.14 $2.45
2022-01-13 $1.84 $2.14 $2.45
2022-01-14 $1.84 $2.15 $2.46
2022-01-17 $1.84 $2.15 $2.46
2022-01-18 $1.85 $2.15 $2.46

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of th... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT